Micron Announces $200 Billion US Investment For Domestic Chip Manufacturing, AI Memory Production
Micron Technology Inc. (NASDAQ:MU) is one of the 11 most profitable NASDAQ stocks to buy now.
Author Archive - Maham Fatima
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer
AstraZeneca (NASDAQ:AZN) is one of the 8 Best Inexpensive Stocks to Buy Right Now.
BofA Lifts Seagate Technology (STX) PT to $145 Following BofA Global Technology Conference
Seagate Technology Holdings (NASDAQ:STX) is one of the 8 Best Inexpensive Stocks to Buy Right Now.
Morgan Stanley Raises Tenet Healthcare (THC) PT to $210, Keeps Overweight Rating
Tenet Healthcare Corporation (NYSE:THC) is one of the 8 Best Inexpensive Stocks to Buy Right Now.
Morgan Stanley Initiates Centene (CNC) with Overweight Rating, Sets $70 PT
Centene Corporation (NYSE:CNC) is one of the 8 Best Inexpensive Stocks to Buy Right Now.
Morgan Stanley Upgrades HCA Healthcare (HCA) PT to $410, Keeps Equal Weight Rating
HCA Healthcare Inc. (NYSE:HCA) is one of the 8 Best Inexpensive Stocks to Buy Right Now.
Truist Lowers Elevance Health (ELV) to $500, Keeps Buy Rating
Elevance Health Inc. (NYSE:ELV) is one of the 8 Best Inexpensive Stocks to Buy Right Now.
BofA Raises Western Digital (WDC) PT to $71 Following 2025 BofA Global Technology Conference
Western Digital Corporation (NASDAQ:WDC) is one of the 8 Best Inexpensive Stocks to Buy Right Now.
Qualcomm Expands into AI Data Centers with Alphawave IP Acquisition
Qualcomm Incorporated (NASDAQ:QCOM) is one of the 8 Best Inexpensive Stocks to Buy Right Now.
Arch Capital Group Taps Wilqo’s Charlie Platform to Revolutionize Mortgage Lending
Arch Capital Group Ltd. (NASDAQ:ACGL) is one of the 11 most profitable NASDAQ stocks to buy now.
Huntington Bancshares Expands Commercial Banking into Florida
Huntington Bancshares Incorporated (NASDAQ:HBAN) is one of the 11 most profitable NASDAQ stocks to buy now.
JPMorgan Raises eBay (EBAY) PT to $66, Keeps Neutral Rating Amid Q1 2025 Performance
eBay Inc. (NASDAQ:EBAY) is one of the 11 most profitable NASDAQ stocks to buy now.
Biogen, UCB Present Positive Phase 3 Results for Lupus Drug Candidate at EULAR 2025
Biogen Inc. (NASDAQ:BIIB) is one of the 11 most profitable NASDAQ stocks to buy now.
Expedia Group Unveils AI-Powered B2B Platform Enhancements, New API Capabilities at EXPLORE Event
Expedia Group Inc. (NASDAQ:EXPE) is one of the 11 most profitable NASDAQ stocks to buy now.
Regeneron, Sanofi Announce Positive Dupixent Results for Atopic Dermatitis
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the 11 most profitable NASDAQ stocks to buy now.
Amgen Announces Significant Survival Benefit for Lung Cancer Drug IMDELLTRA in Phase 3 Trial
Amgen Inc. (NASDAQ:AMGN) is one of the 11 most profitable NASDAQ stocks to buy now.
RBC Capital Lifts Gilead Sciences (GILD) PT to $95 On Insights From a 2022 Patient Survey
Gilead Sciences Inc. (NASDAQ:GILD) is one of the 11 most profitable NASDAQ stocks to buy now.
Comcast Begins Construction of Next-Gen Internet Network Across 7 Indiana Counties
Comcast Corporation (NASDAQ:CMCSA) is one of the 11 most profitable NASDAQ stocks to buy now.
Qualcomm Launches AI R&D Center in Vietnam to Advance Generative, Agentic AI Solutions
Qualcomm Incorporated (NASDAQ:QCOM) is one of the 11 most profitable NASDAQ stocks to buy now.
11 Most Profitable NASDAQ Stocks to Buy Now
Earlier on May 30, Siebert Financial CIO Mark Malek appeared on CNBC to discuss the tariff headwinds swirling around the markets and which sectors could then rise above the noise...
8 Best Inexpensive Stocks to Buy Right Now
On June 7, Torsten Slok, Apollo Global Management, joined 'Closing Bell Overtime' on CNBC to discuss the US jobs report and the broader economic landscape.
Goldman Sachs Upgrades Bayer (BAYRY) to Buy
This upgrade follows Bayer's strong operational start to the year, characterized by cost discipline in its Crop Science division and robust momentum in its underlying Pharmaceuticals...
Morgan Stanley Raises Sprinklr (CXM) PT to $10, Maintains Equal Weight Rating
On Thursday, Morgan Stanley analyst Elizabeth Porter raised the price target on Sprinklr Inc.
RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results
On Thursday, Ascendiant analyst Edward Woo raised the price target on RenovoRx Inc. (NASDAQ:RNXT) to $11.50 from $11, while maintaining a Buy rating on the shares.
Google Pauses ‘Ask Photos’ AI Rollout for Refinement
On June 3, Alphabet Inc. (NASDAQ:GOOGL) quietly paused the rollout of its 'Ask Photos' AI search feature, which had been gradually expanding since last fall.
Morgan Stanley Downgrades Coursera (COUR) to Equal Weight, Lifts PT to $11
The adjustment came as Morgan Stanley noted that Coursera currently trades at a premium valuation compared to Udemy Inc. (NASDAQ:UDMY).
AMD Acquires Brium to Boost AI Performance, Challenges Nvidia’s Dominance
On June 4, Advanced Micro Devices Inc.
Amazon to Test Humanoid Robots for Last-Mile Delivery With Rivian Vans
On June 4, Amazon Inc. (NASDAQ:AMZN) announced plans to begin testing humanoid robots for package delivery.
Bell Media Partners with Magna for Autonomous Vehicle Advertising in Toronto
On Thursday, BCE Inc.
Avadel Pharmaceuticals Receives Orphan Drug Designation for LUMRYZ in IH
On Thursday, Avadel Pharmaceuticals (NASDAQ:AVDL) announced that its drug LUMRYZ (sodium oxybate) for extended-release oral suspension has been granted Orphan Drug Designation...
Colliers Completes Acquisition of Triovest
On Thursday, Colliers International Group Inc. (NASDAQ:CIGI) announced the completion of its previously announced acquisition of Triovest Inc.
Ballard Power Systems Secures 1.5MW Fuel Cell Order for California Rail Decarbonization
On Thursday, Ballard Power Systems Inc.
Cellebrite DI to Acquire Corellium for $170M
The acquisition is valued at an enterprise value of $170 million in cash, with $20 million converted to equity at closing.
Estrella Immunopharma Expands STARLIGHT-1 Trial with New Texas Clinical Site
The trial is evaluating EB103, which is a CD19-redirected ARTEMIS® T-cell therapy, in adult patients (aged 18 and older) with relapsed or refractory B-cell non-Hodgkin’s lymphoma...
BYD To Triple Its South African Dealerships By 2026
On Thursday, BYD Company Limited (OTC:BYDDF) announced plans to nearly triple its dealership network in South Africa by 2026.
Blink Charging, WirelessCar, and ChargeHub Launch Seamless Charging EV Pilot in North America
On June 3, WirelessCar announced a collaboration with Blink Charging Co. (NASDAQ:BLNK) and ChargeHub.
Iridium Launches Chat App, Unlimited Plan for Enhanced Global Off-Grid Messaging
On June 3, Iridium Communications Inc. (NASDAQ:IRDM) announced the launch of its new Iridium Chat app.
Fidelity National Tapped by ATLAS SP Partners to Support Commercial Loan Servicing
On June 3, Fidelity National Information Services Inc. (NYSE:FIS) announced that ATLAS SP Partners selected its Commercial Loan Servicing solution.
Snapchat Unveils Standalone App for Making GenAI AR effects
On June 4, Snap Inc. (NYSE:SNAP) officially launched new and more accessible versions of its Lens Studio: a standalone iOS app and a web tool.
Amneal Pharmaceuticals Initiates Nationwide Recall of Contaminated Sulfamethoxazole/Trimethoprim Tablets
On June 1, Amneal Pharmaceuticals Inc. (NASDAQ:AMRX) initiated a nationwide recall of 3 specific lots of its Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg.
IBM and Inclusive Brains Partner to Advance Mind-Controlled Computing with AI, Quantum Tech
On June 3, International Business Machines Corporation (NYSE:IBM) and French startup Inclusive Brains announced a joint study agreement to advance mind-controlled computing.
Citi Raises Barclays (BCS) PT to 360 GBp on Strong Q1 2025 Performance
In Q1 2025, Barclays reported a Return on Tangible Equity (RoTE) of 14% for. Total income for the quarter was GBP7.7 billion, with a cost-income ratio of 57%.
Barclays Boosts Argenx (ARGX) PT to EUR 680 After Strong Q1 2025 Performance
On June 4, Barclays raised its price target for Argenx (NASDAQ:ARGX) from EUR 650 to EUR 680, while keeping an Overweight rating on the company's shares.
Wells Fargo Raises Celsius (CELH) PT to $45, Maintains Overweight Rating
On June 4, Wells Fargo increased its price target for Celsius Holdings Inc. (NASDAQ:CELH) to $45 from $44, while maintaining an Overweight rating.
Baird Raises Donaldson (DCI) PT to $78 After Solid FQ3 2025 Performance
On June 4, Baird analyst Robert Mason increased the price target on Donaldson Company Inc. (NYSE:DCI) to $78 from $76, while maintaining an Outperform rating on the shares.
Baird Lifts Agenus (AGEN) PT to $6, Maintains Neutral Rating
This adjustment reflects an updated financial model following Agenus's receipt of a $91 million upfront payment from its collaboration with Zydus.
Piper Sandler Boosts TransMedics (TMDX) PT to $145, Keeps Overweight Rating
On Wednesday, Piper Sandler analyst Matt O’Brien raised the price target on TransMedics Group Inc.
JPMorgan Elevates Amazon (AMZN) PT to $240 on Strong Q1 Report
On Wednesday, JPMorgan analyst Doug Anmuth raised the price target for Amazon.com Inc. (NASDAQ:AMZN) to $240 from $225, while maintaining an Overweight rating on the shares.
UBS Raises BBB Foods (TBBB) PT to $33, Keeps Neutral Rating
On Wednesday, UBS raised its price target for BBB Foods Inc. (NYSE:TBBB) from $32 to $33, while maintaining a Neutral rating on the company's shares.
UBS Raises Ambev (ABEV) PT to $2.70, Keeps Neutral Rating
On Wednesday, UBS raised its price target for Ambev (NYSE:ABEV) from $2.60 to $2.70, while maintaining a Neutral rating on the shares.
